The United Kingdom is poised to provide NHS patients with access to new medicines previously deemed unaffordable under a sweeping agreement with the United States. Under the deal, NHS expenditure
All posts tagged in drug pricing
9Articles
The UK is facing mounting pressure from the United States to reform its drug pricing policies, with the US ambassador, Warren Stephens, delivering a stark ultimatum to government officials and
Sir Keir Starmer is preparing to overhaul NHS value for money protocols in a high-stakes move that could see Britain pour billions more into pharmaceutical spending. This comes amid escalating
Moderna has marked a significant milestone in the UK pharmaceuticals landscape by launching a £150m manufacturing and research facility in Oxfordshire. The ribbon-cutting ceremony, attended by Moderna’s chief executive Stéphane
Bristol Myers Squibb BMS has issued a pointed demand for the NHS to fund a greater share of pharmaceutical innovation calling for the UK to pay what it describes as
The battle between the NHS and pharmaceutical giants is reaching boiling point as accusations fly over the UK’s approach to funding modern medicines. A fresh row has ignited during President
Eli Lilly, the US manufacturer of the weight management injection Mounjaro, has announced a new discount for private pharmacies in the UK. The move follows widespread concern after the company
Britain faces a growing crisis in its life sciences sector as a senior executive at Novartis has declared the UK “uninvestable” owing to stringent and outdated drug pricing policies. Johan
Eli Lilly, one of the world’s largest pharmaceutical companies, has temporarily halted orders of its highly sought-after weight-loss injection, Mounjaro, to the UK. This move comes as the market braces
